The low-AAMRGS subgroup displayed higher immune scores, enriched extensive infiltration of anti-tumor cells (type 1 T helper cells, CD8 + T cells), upper immune activity of immune cycle, and greater expression of immunostimulators and MHC. This evidence concerns the gene HLA-C and neoplasm.